Rhine-novation in Biologics

Novalix is pleased to announce its participation as a speaker at the first Swiss Biologics Seminar organized by Revvity.
This event will featuring insights on the latest advances in Biologics and networking opportunities with your peers in a charming setting close to Novartis campus.

“Tools and methods to characterize ADCs”

Do not miss the talk from Julia Frappier, Senior Scientist, in vitro Pharmacology.

She will discuss cutting-edge innovations together with other renowned speakers, such as:
Nicolas Viaud | Innate Pharma, Pre-clinical Project Manager
→ “IPH4502, a differentiated Nectin-4 exatecan antibody-drug conjugate”

Jean-Philippe Pin | Institute of Functional Genomics (IGF, Montpellier), Director of Research
→ “Nanobodies® as new potential therapeutic tools for brain diseases: a proof of concept with potentiators of mGlu2”

Eric Trinquet | Revvity, Senior R&D Director
→ “Innovative solutions for Antibody and ADC internalisation monitoring”

This event is free to attend, but seats are limited. Register here: Rhine-novation in Biologics
If you are also attending, set a meeting and catch up. We look forward to meeting you there!